SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Ed Ajootian who wrote (1201)9/24/1998 9:43:00 PM
From: chum slury  Read Replies (2) | Respond to of 10280
 
It looks like David Southwell bailed out on 165,000 shares at a average price of $50.07 for a total of $8,261,718.00. I wonder if he treated himself to a beer afterwards.



To: Ed Ajootian who wrote (1201)9/25/1998 9:12:00 PM
From: John Metcalf  Read Replies (1) | Respond to of 10280
 
Ed, I haven't found the Soros filing yet, though I've been very interested. It was widely reported that Soros lost $2B in Russia, and therefore would need to sell other positions. I've been wondering whether this liquidity problem (for Soros personally, or for Quantum Fund) was behind the recent sharp decent of Pharmacyclics as well.

Do you have any more detail on the filing? Can you compare it to previous 13-D's?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News